143 related articles for article (PubMed ID: 27002759)
1. New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
Cybula M; Wieteska Ƚ; Józefowicz-Korczyńska M; Karbownik MS; Grzelczyk WL; Szemraj J
Cancer Biomark; 2016; 16(4):559-68. PubMed ID: 27002759
[TBL] [Abstract][Full Text] [Related]
2. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
3. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
4. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
[TBL] [Abstract][Full Text] [Related]
7. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
[TBL] [Abstract][Full Text] [Related]
8. [Growth inhibitory effect of microRNA-519b-3p on larynx squamous Hep-2 cells].
Shen Z; Zhan G; Deng H; Kang C; Guo J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 49(2):151-6. PubMed ID: 24742516
[TBL] [Abstract][Full Text] [Related]
9. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
[TBL] [Abstract][Full Text] [Related]
10. miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p.
Yang X; Wu X
Oncol Rep; 2016 Jan; 35(1):398-408. PubMed ID: 26498065
[TBL] [Abstract][Full Text] [Related]
11. Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.
Sand M; Hessam S; Amur S; Skrygan M; Bromba M; Stockfleth E; Gambichler T; Bechara FG
J Dermatol Sci; 2017 May; 86(2):142-148. PubMed ID: 28187958
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients.
Garo Kyurkchiyan S; Miroslavov Popov T; Stancheva G; Rangachev J; Ivanov Mitev V; Petrova Popova D; Petrova Kaneva R
J BUON; 2020; 25(1):357-366. PubMed ID: 32277655
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
Geng J; Liu Y; Jin Y; Tai J; Zhang J; Xiao X; Chu P; Yu Y; Wang SC; Lu J; Han S; Shi J; Guo Y; Ni X
Oncol Rep; 2016 Apr; 35(4):2017-26. PubMed ID: 26883008
[TBL] [Abstract][Full Text] [Related]
14. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
15. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
16. [Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
Hu A; Jin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):788-92. PubMed ID: 23259291
[TBL] [Abstract][Full Text] [Related]
17. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.
Cao P; Zhou L; Zhang J; Zheng F; Wang H; Ma D; Tian J
Head Neck; 2013 May; 35(5):720-8. PubMed ID: 22605671
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-145-5p-Centered Competing Endogenous RNA Network in Laryngeal Squamous Cell Carcinoma.
Gao W; Zhang Y; Niu M; Bo Y; Li H; Xue X; Lu Y; Zheng X; Tang Y; Cui J; He L; Thorne RF; Wang B; Wu Y
Proteomics; 2019 Nov; 19(21-22):e1900020. PubMed ID: 31169343
[TBL] [Abstract][Full Text] [Related]
20. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]